Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chien Chou

Showing results (431-440 of 528) with videos related to

Pageof 53
Sort By:
Investigative Ophthalmology & Visual Science|August 1, 2025
Clinical Manifestations and Ophthalmic Outcomes of Leukemic Retinopathy and Optic Neuropathy in Patients With Acute LeukemiaChi-Ying Chen, Jia-Pang Jhang, Ying-Ju Lai, et al.
Neuron|October 17, 2017
Differential Regulation of Evoked and Spontaneous Release by Presynaptic NMDA ReceptorsTherése Abrahamsson, Christina You Chien Chou, Si Ying Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2012
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemiaHagop M Kantarjian, Xavier G Thomas, Anna Dmoszynska, et al.
Cancers|November 19, 2020
Ex Vivo Expansion and Drug Sensitivity Profiling of Circulating Tumor Cells from Patients with Small Cell Lung CancerHsin-Lun Lee, Jeng-Fong Chiou, Peng-Yuan Wang, et al.
Molecular Cancer Therapeutics|September 20, 2011
Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growthF Michael Yakes, Jason Chen, Jenny Tan, et al.
Annals of Hematology|April 2, 2014
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myelomaShang-Yi Huang, Chung-Wu Lin, Hsiu-Hsia Lin, et al.
Cancer Research|March 17, 2006
Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolutionWen-Chien Chou, Jih-Luh Tang, Liang-In Lin, et al.
Annals of Hematology|January 23, 2020
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclaxYu-Wen Wang, Cheng-Hong Tsai, Chien-Chin Lin, et al.
British Journal of Haematology|February 6, 2023
A three-gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemiaYu-Hung Wang, Chi-Yuan Yao, Chien-Chin Lin, et al.
Scientific Reports|December 3, 2024
Factors influencing the decision to receive total knee replacement among patients with severe knee osteoarthritis under universal health insurance coverageCheng-Chi Wang, Kui-Chou Huang, Ming-Chou Ku, et al.
Pageof 53

Showing results (431-440 of 528) with videos related to

Sort By:
Pageof 53
Investigative Ophthalmology & Visual Science|August 1, 2025
Clinical Manifestations and Ophthalmic Outcomes of Leukemic Retinopathy and Optic Neuropathy in Patients With Acute LeukemiaChi-Ying Chen, Jia-Pang Jhang, Ying-Ju Lai, et al.
Neuron|October 17, 2017
Differential Regulation of Evoked and Spontaneous Release by Presynaptic NMDA ReceptorsTherése Abrahamsson, Christina You Chien Chou, Si Ying Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2012
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemiaHagop M Kantarjian, Xavier G Thomas, Anna Dmoszynska, et al.
Cancers|November 19, 2020
Ex Vivo Expansion and Drug Sensitivity Profiling of Circulating Tumor Cells from Patients with Small Cell Lung CancerHsin-Lun Lee, Jeng-Fong Chiou, Peng-Yuan Wang, et al.
Molecular Cancer Therapeutics|September 20, 2011
Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growthF Michael Yakes, Jason Chen, Jenny Tan, et al.
Annals of Hematology|April 2, 2014
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myelomaShang-Yi Huang, Chung-Wu Lin, Hsiu-Hsia Lin, et al.
Cancer Research|March 17, 2006
Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolutionWen-Chien Chou, Jih-Luh Tang, Liang-In Lin, et al.
Annals of Hematology|January 23, 2020
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclaxYu-Wen Wang, Cheng-Hong Tsai, Chien-Chin Lin, et al.
British Journal of Haematology|February 6, 2023
A three-gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemiaYu-Hung Wang, Chi-Yuan Yao, Chien-Chin Lin, et al.
Scientific Reports|December 3, 2024
Factors influencing the decision to receive total knee replacement among patients with severe knee osteoarthritis under universal health insurance coverageCheng-Chi Wang, Kui-Chou Huang, Ming-Chou Ku, et al.
Pageof 53